2021 annual financial data
Tarsus Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was -21.32%.
Operating income was -12,157,000 USD and net income was -13,827,000 USD.
Operating cash flow was 3,748,000 USD.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,027,000 USD
- Operating income
- -12,157,000 USD
- Net income
- -13,827,000 USD
- Operating cash flow
- 3,748,000 USD